Publications by authors named "Jonas Blaes"

13Publications

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.

Clin Cancer Res 2016 Dec 12;22(24):6078-6087. Epub 2016 Aug 12.

Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1327DOI Listing
December 2016

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.

Cancer Lett 2016 10 20;380(2):568-76. Epub 2015 Aug 20.

Department of Neurosurgery, Neurochirurgische Klinik - Universitätsmedizin Charite, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.06.026DOI Listing
October 2016

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.

Glia 2015 Jan 5;63(1):78-90. Epub 2014 Aug 5.

German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/glia.22734DOI Listing
January 2015

Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival.

Cell Stem Cell 2014 Aug 15;15(2):185-98. Epub 2014 May 15.

Helmholtz Young Investigator Group, Normal and Neoplastic CNS Stem Cells, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19345909140014
Publisher Site
http://dx.doi.org/10.1016/j.stem.2014.04.007DOI Listing
August 2014

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Proc Natl Acad Sci U S A 2014 Jan 23;111(1):409-14. Epub 2013 Dec 23.

German Cancer Consortium, Clinical Cooperation Units Neurooncology and Neuropathology, Helmholtz Group Experimental Neuroimmunology, Small Animal Imaging Facility, Biostatistics, and Functional Proteome Analysis, German Cancer Research Center, D-69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1314469111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890826PMC
January 2014

mTORC 2:1 for chemotherapy sensitization in glioblastoma.

Cancer Discov 2011 Nov;1(6):475-6

Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Department of Neurooncology at the National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-11-0264DOI Listing
November 2011